MOLLY BROTHERSON: Open Payments
NPI 1578598132 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 31 payments from 12 companies in 2025. Trend: 2023 $1,095 · 2024 $990 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $144 |
| Travere Therapeutics, Inc. | 3 | $94 |
| ANI Pharmaceuticals, Inc. | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Vifor Pharma, Inc. | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Amgen Inc. | 2 | $28 |
| Novo Nordisk Inc | 1 | $25 |
| Ardelyx, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: Kerendia, PURIFIED CORTROPHIN GEL, Veltassa, BENLYSTA, Rivfloza, LOKELMA, IBSRELA, JARDIANCE.
Industry payments across UT — which companies pay providers there.
